Echo Therapeutics (ECTE) Closes 3.2M Offering at 95c/Share
Tweet Send to a FriendGet Alerts ECTE Hot Sheet
Up)
Trade ECTE Now!
Echo Therapeutics, Inc. (Nasdaq: ECTE) announced the closing of a previously announced underwritten public offering of 3,200,000 shares of its common stock and the fully exercised over-allotment option to purchase 480,000 additional shares, offered at a price of $0.95 per share. The gross proceeds to Echo from this offering were approximately $3.5 million, before deducting the underwriting discount and other offering expenses payable by Echo.
Aegis Capital Corp. acted as the sole book-running manager for the offering.
Feltl and Company acted as co-manager for the offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Aegis Capital Corp. acted as the sole book-running manager for the offering.
Feltl and Company acted as co-manager for the offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Echo Therapeutics (ECTE) Gets IRB Approval for Symphony CGM System
- Blackstone Mortgage (BXMT) Prices Larger 22.5M Common Stock Offering
- Hewlett-Packard (HPQ) Q2 Performance Wins Praise on Wall Street; Jefferies Raises to Hold
Create E-mail Alert Related Categories
Credit Ratings, Equity Offerings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
